These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18201201

  • 1. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.
    Zhang H, Deng JY, Bi LJ, Zhou YF, Zhang ZP, Zhang CG, Zhang Y, Zhang XE.
    FEBS J; 2008 Feb; 275(4):753-62. PubMed ID: 18201201
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
    Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W.
    PLoS One; 2011 Jan 24; 6(1):e15785. PubMed ID: 21283666
    [Abstract] [Full Text] [Related]

  • 3. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
    Barco P, Cardoso RF, Hirata RD, Leite CQ, Pandolfi JR, Sato DN, Shikama ML, de Melo FF, Mamizuka EM, Campanerut PA, Hirata MH.
    J Antimicrob Chemother; 2006 Nov 24; 58(5):930-5. PubMed ID: 16971417
    [Abstract] [Full Text] [Related]

  • 4. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P, Mishra AK, Malonia SK, Chauhan DS, Sharma VD, Venkatesan K, Katoch VM.
    J Commun Dis; 2006 Mar 24; 38(3):288-98. PubMed ID: 17373362
    [Abstract] [Full Text] [Related]

  • 5. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
    Doustdar F, Pazhang M, Mehrnejad F, Safarzadeh M, Rabiei D, Chaparzadeh N, Falahati H, Mir-Derikvand M.
    Protein J; 2015 Jun 24; 34(3):181-92. PubMed ID: 25972249
    [Abstract] [Full Text] [Related]

  • 6. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M, Sheen P, Quiliano M, Gutierrez A, Gilman RH.
    Infect Genet Evol; 2010 Mar 24; 10(2):346-9. PubMed ID: 19963078
    [Abstract] [Full Text] [Related]

  • 7. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
    Scorpio A, Zhang Y.
    Nat Med; 1996 Jun 24; 2(6):662-7. PubMed ID: 8640557
    [Abstract] [Full Text] [Related]

  • 8. Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.
    Seiner DR, Hegde SS, Blanchard JS.
    Biochemistry; 2010 Nov 09; 49(44):9613-9. PubMed ID: 20879713
    [Abstract] [Full Text] [Related]

  • 9. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
    Yoon JH, Nam JS, Kim KJ, Ro YT.
    World J Microbiol Biotechnol; 2014 Nov 09; 30(11):2821-8. PubMed ID: 25034468
    [Abstract] [Full Text] [Related]

  • 10. The carboxy-terminal end of the peptide deformylase from Mycobacterium tuberculosis is indispensable for its enzymatic activity.
    Saxena R, Chakraborti PK.
    Biochem Biophys Res Commun; 2005 Jul 01; 332(2):418-25. PubMed ID: 15896710
    [Abstract] [Full Text] [Related]

  • 11. Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
    Supo-Escalante RR, Médico A, Gushiken E, Olivos-Ramírez GE, Quispe Y, Torres F, Zamudio M, Antiparra R, Amzel LM, Gilman RH, Sheen P, Zimic M.
    PLoS One; 2020 Jul 01; 15(7):e0235643. PubMed ID: 32735615
    [Abstract] [Full Text] [Related]

  • 12. [Nicotinamidase and the so-called pyrazinamidase in mycobacteria; the simultaneous occurrence of both activites (author's transl)].
    Tarnok I, Pechmann H, Krallmann-Wenzel U, Röhrscheidt E, Tarnok Z.
    Zentralbl Bakteriol Orig A; 1979 Jul 01; 244(2-3):302-8. PubMed ID: 506551
    [Abstract] [Full Text] [Related]

  • 13. The curious characteristics of pyrazinamide: a review.
    Zhang Y, Mitchison D.
    Int J Tuberc Lung Dis; 2003 Jan 01; 7(1):6-21. PubMed ID: 12701830
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Isolation and molecular characterization of a novel D-hydantoinase from Jannaschia sp. CCS1.
    Cai Y, Trodler P, Jiang S, Zhang W, Wu Y, Lu Y, Yang S, Jiang W.
    FEBS J; 2009 Jul 01; 276(13):3575-88. PubMed ID: 19490017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enzymatic activity of Campylobacter jejuni hippurate hydrolase.
    Steele M, Marcone M, Gyles C, Chan VL, Odumeru J.
    Protein Eng Des Sel; 2006 Jan 01; 19(1):17-25. PubMed ID: 16303789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.